ACTHAR Therapy for Central Nervous System Sarcoidosis

Trial Profile

ACTHAR Therapy for Central Nervous System Sarcoidosis

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2018

At a glance

  • Drugs Corticotropin (Primary)
  • Indications Sarcoidosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Feb 2018 Planned initiation date changed from 1 Oct 2016 to 1 Jun 2018.
    • 04 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top